Results 181 to 190 of about 12,450 (234)

Evaluation of Reduced Single-Photon Emission Computed Tomography Imaging Protocols and Software Variability in ¹⁷⁷Lu-DOTATATE Dosimetry: Protocol for an Exploratory Observational Trial.

JMIR Res Protoc
Yagihashi T, Miwa K, Miyaji N, Sugimoto S, Hayakawa H, Kobayashi N, Takano S, Murai T.   +7 more
europepmc   +1 more source

Clinical Image-Based Dosimetry of Actinium-225 in Targeted Alpha Therapy. [PDF]

Cancers (Basel)
Ramonaheng K, Banda K, Qebetu M, Goorhoo P, Legodi K, Masogo T, Seebarruth Y, Mdanda S, Sibiya S, Mzizi Y, Davis C, Smith L, Ndlovu H, Kabunda J, Maes A, Van de Wiele C, Al-Ibraheem A, Sathekge M.   +17 more
europepmc   +1 more source

Pathways and challenges in the clinical translational of radiopharmaceuticals for pediatric investigations. [PDF]

Front Med (Lausanne)
Stauff E, Karimi H, Kecskemethy HH, Shaffer TH, Vali R, Averill LW, Yue X.   +6 more
europepmc   +1 more source

Enhancing Cytosolic Internalization of [¹⁷⁷Lu]Lu-iPSMA in Prostate Cancer Cells: The Effect of Conjugating a GRP78 Inhibitor to the Radiotherapeutic Molecule. [PDF]

Int J Mol Sci
Azorín-Vega E, García-Arce D, Luna-Gutiérrez M, Ocampo-García B, Trujillo-Benítez D, Vidal-Limon A, Rodríguez-Martínez G, Durán-Pastén ML, Meléndez-Alafort L, Ferro-Flores G.   +9 more
europepmc   +1 more source

Correction to: Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology. [PDF]

Int J Clin Oncol
Suzuki K, Miyake H, Inaki A, Takano S, Kuboki Y, Mizowaki T, Nakamura K, Ueno M, Matsumoto S, Obinata D, Nakagawa T, Murakami M, Majima Y, Yokono M, Namba M, Yoshino T.   +15 more
europepmc   +1 more source

La-[^18/19F]fluoride complexes: a novel addition to the radiofluorination family.

Dalton Trans
Behe M, Gruber S, Li C, Schreckenbach G, Mu L, Schottelius M, Faizova R.   +6 more
europepmc   +1 more source

Establishment of National Diagnostic Reference Levels 2025 for nuclear medicine in Japan. [PDF]

Ann Nucl Med
Abe K, Baba S, Etani R, Fujimto T, Hosono M, Iimori T, Inaki A, Ishiguro M, Miyaji N, Okizaki A, Sasaki T, Tsushima H, Watanabe H, Watanabe M, Yada N.   +14 more
europepmc   +1 more source

Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy. [PDF]

J Immunother Cancer
Zhang S, Liu C, Lu Q, Liu W, Wu J, Liu J, Tong L, Zhao K, Hu Q, Chen X, Li L, Song X, Wang F, Dai D, Wang R, Hu K.   +15 more
europepmc   +1 more source

Streamlining first-in-human PET radiopharmaceutical development: FDA's evolving stance on preclinical dosimetry. [PDF]

Am J Nucl Med Mol Imaging
Zhao T, Liang SH.
europepmc   +1 more source

¹⁸F-Radiopharmaceutical Diversification Enabled by Deaminative Cross-Electrophile Couplings. [PDF]

Angew Chem Int Ed Engl
Ogilvy IF, Ford J, Ortalli S, Renders E, Hayes TR, Liu S, Mortiers I, Nikolopoulou A, Sorlin AM, Trabanco AA, Tredwell M, Buijnsters PJJA, Salter R, Gouverneur V.   +13 more
europepmc   +1 more source